v3.26.1
Share-Based Compensation (Tables)
 12 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Share-Based Compensation Plans Total share-based compensation included as a component of selling, general and administrative expenses in our Consolidated Income Statements was as follows:
Fiscal Year Ended June 30,
202620252024
(in thousands)
Share-based compensation related to:
Equity classified stock options$— $— $550 
Equity classified restricted stock14,063 11,062 8,987 
Total share-based compensation$14,063 $11,062 $9,537 
Schedule of Stock Option Plans
A summary of activity under our stock option plans is presented below:

Fiscal Year Ended June 30, 2026
OptionsWeighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Life		Aggregate
Intrinsic
Value
Outstanding, beginning of year435,663 $32.71 
Granted during the period— — 
Exercised during the period(133,700)37.71 
Canceled, forfeited, or expired during the period— — 
Outstanding, end of year301,963 30.49 2.86$6,521,546 
Vested at June 30, 2026301,963 30.49 2.86$6,521,546 
Exercisable, end of year301,963 $30.49 2.86$6,521,546 
Schedule of Stock Options Outstanding The following table summarizes information about stock options outstanding and exercisable as of June 30, 2026:
Options OutstandingOptions Exercisable
Range of Exercise PricesShares
  Outstanding		Weighted
Average
Remaining
  Contractual Life		Weighted Average
Exercise
Price		Number ExercisableWeighted Average
Exercise
Price
$22.27 - $26.38
52,524 4.3924.61 52,524 24.61 
$26.38 - $30.49
119,021 4.4027.14 119,021 27.14 
$30.49 - $34.60
53,079 1.4434.35 53,079 34.35 
$34.60 - $38.71
77,339 0.4237.00 77,339 37.00 
301,963 2.86$30.49 301,963 $30.49 
Schedule of Restricted Stock Outstanding
During the fiscal year ended June 30, 2026, the Company granted 417,961 shares of restricted stock to employees and non-employee directors, all of which were issued in the form of RSUs:
Fiscal Year Ended June 30, 2026
Shares
granted		Date grantedGrant date
fair value		Vesting period
Employees
Certain employees based on performance284,083 September 1, 2025$43.65 
Annually over 4 years
Certain employees based on performance107,546 September 1, 2025$43.65 
Annually over 3 years
Certain employees based on performance481 November 11, 2025$40.65 
Annually over 4 years
Non-Employee Directors
Certain Directors25,851 September 1, 2025$43.65 
12 months
A summary of the status of the Company’s outstanding restricted stock is presented below:

Fiscal Year Ended June 30, 2026
SharesWeighted-Average
Grant Date Fair
Value
Outstanding, beginning of year901,255 $40.52 
Granted during the period417,961 43.33 
Vested during the period(301,142)36.35 
Cancelled, forfeited, or expired during the period(105,738)35.60 
Outstanding, end of year912,336 $42.43